Finance

Beta
Lists
BBOT:NASDAQ
BridgeBio Oncology Therapeutics Inc
$7.26
-6.68%
(-0.52) 1D
$7.26
0.00% (0.00)
After hours
Closed: Jun 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBOT...
Open
$7.95
High
$8.15
Low
$7.23
Mkt. cap
581.04M
Avg. vol.
361.20K
Volume
426.17K
52-wk high
$14.87
52-wk low
$7.23
Shares outstanding
80.11M
No. of employees
106
Open
$7.95
High
$8.15
Low
$7.23
Mkt. cap
581.04M
Avg. vol.
361.20K
Volume
426.17K
52-wk high
$14.87
52-wk low
$7.23
Shares outstanding
80.11M
No. of employees
106
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to BBOT in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BBOT in the last 3 months.
Highest
Current $7.26
$29.00 (+299.45%)
Average
$23.00 (+216.80%)
Lowest
$18.00 (+147.93%)
News stories
From sources across the web
About BridgeBio Oncology Therapeutics Inc
CEO-
Employees106
Founded2016
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitebbotx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
27.44M
35.05M
38.07M
39.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.66M
14.13M
5.33M
6.38M
Operating expense
30.09M
49.18M
43.41M
46.18M
Total operating expenses
30.09M
49.18M
43.41M
46.18M
Operating income
-30.09M
-49.18M
-43.41M
-46.18M
Other non operating income
-8.00K
980.00K
187.00K
129.00K
EBT including unusual items
-28.44M
-44.76M
-38.80M
-42.11M
EBT excluding unusual items
-28.44M
-44.76M
-38.80M
-42.11M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-28.44M
-44.76M
-38.80M
-42.11M
Net profit margin
-
-
-
-
Earnings per share
-
-1.03
-0.49
-0.53
Interest and investment income
1.67M
3.44M
4.42M
3.94M
Interest expense
-
-
-
-
Net interest expenses
1.67M
3.44M
4.42M
3.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.02M
-49.11M
-43.32M
-46.10M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer